US Stock MarketDetailed Quotes

PTGX Protagonist Therapeutics

Watchlist

46.900
+0.440+0.95%

Trading Nov 25 10:02 ET

2.80BMarket Cap17.12P/E (TTM)

Protagonist Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Protagonist Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 43.918M	--
--	2024/Q4	-- / 61.169M	--
--	2024/Q3	4.675M / 1.813M	--
--	2024/Q2	4.167M / 6.667M	--
--	2024/Q1	254.953M / 120.000M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 43.918M--

--2024/Q4-- / 61.169M--

--2024/Q34.675M / 1.813M--

--2024/Q24.167M / 6.667M--

--2024/Q1254.953M / 120.000M--

Unlock Free Earnings Estimates

Open Account

Protagonist Therapeutics Earnings Reports

Protagonist Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7 22:36 ET

Protagonist Therapeutics | 8-K: Protagonist Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 7 16:15 ET

Protagonist Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 6 16:24 ET

Protagonist Therapeutics | 8-K: Protagonist Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 6 07:13 ET

Analyst Rating

Updated: Nov 25, 2024

Strong Buy

Buy
83.33%
Hold
16.67%
Sell
0.00%

Price Target

No Data

Heat List

Overall